Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis

Hepatology

Volumn 56, Issue 4, 2012, Pages 1409-1417

  Liang, Yan ^a   Yang, Zaixing ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; COLON CANCER; COLORECTAL CANCER; EMBASE; ESOPHAGUS CANCER; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MEDLINE; MELANOMA; META ANALYSIS; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; INCIDENCE; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 84867208789     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25788     Document Type: Article

References (37)

1. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. HEPATOLOGY 1999; 29: 1425-1428.
2. Krasner P, Johnson PJ, Portmann B, Watkinson G, Macsween RNM, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut 1979; 20: 255-258.
3. Nakanuma Y, Terada T, Doishita K, Miwa A. Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study. HEPATOLOGY 1990; 11: 1010-1016.
4. Shimizu A, Koyama M, Okuda Y, Takase K, Nakano T, Tameda Y. Hepatocellular carcinoma in primary biliary cirrhosis: a case report and review of the Japanese literature. Hepatogastroenterology 1998; 45: 2352-2355.
5. Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol 1994; 21: 315-316.
6. Caballeria L, Parés A, Castells A, Ginés A, Bru C, Rodés J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001; 96: 1160-1163.
7. Deutsch M, Papatheodoridis GV, Tzakou A, Hadziyannis SJ. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2008; 20: 5-9.
8. Piscaglia F, Sagrini E. Malignancies in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2008; 20: 1-4.
9. Silveira MG, Suzuki A, Lindor KD. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. HEPATOLOGY 2008; 48: 1149-1156.
10. Mills PR, Boyle P, Quigley EMM, et al. Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol 1982; 35: 541-543.
11. Goudie BM, Burt AD, Boyle P, Macfarlane G, Birnie GG, Gillis PCR, et al. Breast cancer in women with primary biliary cirrhosis. BMJ 1985; 291: 1597-1598.
12. Wolke AM, Schaffner F, Kapelman B, Sacks HS. Malignancy in primary biliary cirrhosis: high incidence of breast cancer in affected women. Am J Med 1984; 76: 1075-1078.
13. Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011; 117: 1163-1171.
14. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed on March 4, 2012.
15. International Agency for Research on Cancer Cancer Incidence in Five Continents, I to IX: IARC CancerBase No. 9. Available at: http://ci5.iarc.fr. Accessed on December 17, 2011.
16. Taeger D, Sun Y, Keil U, Straif K. A stand-alone Windows applications for computing extract person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology 2000; 11: 607-608.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 589-624.
18. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889-894.
19. Egger M, Davey SG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
20. Cavazza A, Caballería L, Floreani A, Farinati F, Bruguera M, Caroli D, et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. HEPATOLOGY 2009; 50: 1162-1168.
21. Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Collier J. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study. Eur J Gastroenterol Hepatol 2008; 20: 384-392.
22. Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. HEPATOLOGY 2007; 46: 1131-1137.
23. Howel D, Metcalf JV, Gray J, Newman WL, Jones DEJ, James OFW. Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 1999; 45: 756-760.
24. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. HEPATOLOGY 1999; 29: 1396-1398.
25. Lööf L, Adami HO, Sparén P, Danielsson A, Eriksson LS, Hultcrantz R, Lindgren S, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. HEPATOLOGY 1994; 20: 101-104.
26. Witt-Sullivan H, Heathcote J, Cauch K, Blendis L, Ghent C, Katz A, et al. The demography of primary biliary cirrhosis in Ontario, Canada. HEPATOLOGY 1990; 12: 98-105.
27. Ngu JH, Gearry RB, Frampton CM, Stedman CA. Mortality and the risk of malignancy in autoimmune liver diseases: a population based study in Canterbury, New Zealand. HEPATOLOGY 2012; 55: 522-529.
28. Shibuya A, Tanaka K, Miyakawa H, Shibata M, Takatori M, Sekiyama K, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. HEPATOLOGY 2002; 35: 1172-1178.
29. Kuiper EM, Hansen BE, Adang RP, van Nieuwkerk CM, Timmer R, Drenth JP, et al.; Dutch PBC Study Group. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. Eur J Gastroenterol Hepatol 2010; 22: 1495-1502.
30. Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, et al. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int 2008; 28: 1305-1313.
31. Panjala C, Talwalkar JA, Lindor KD. Risk of lymphoma in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 761-764.
32. Sterne J, Becker B, Egger M. The funnel plot. In: Rothstein H, Sutton A, Borenstein M, editors. Publication bias in meta-analysis. prevention, assessment and adjustments. Chichester, United Kingdom: Wiley; 2005.
33. Van Dam GM, Gips CH. Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. Scand J Gastroenterol 1997; 32: 77-83.
34. Bruix J, Boix L, Sala M, Llovet J. BCLC Group Liver Unit. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215-219.
35. Liang Y, Yang Z, Zhong R. Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis: a meta-analysis. Hepatol Res 2011; 41: 572-578.
36. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011; 29: 3775-3782.
37. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Primary biliary cirrhosis. HEPATOLOGY 2009; 50: 291-308.